Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

2 years ago 31
ARTICLE AD BOX
Researchers have found that most cancer drugs granted accelerated approval by the U.S. Food and Drug Administration do not deliver on their early promise
Read Entire Article